
Programs
Departments & Divisions
Institutes & Centers
Research
Clinical
Kermit V Speeg, M.D.
Professor of Medicine
Transplant Hepatologist
Kermit V Speeg PhD (Rice University), MD (UT Southwestern Medical School). Gastroenterology at Vanderbilt University. Presently, Medical Director of Adult Liver Transplant at UT Health-San Antonio and UHS. Practice primarily focuses on acute and chronic liver disease patients and the care of post-transplant patients from either deceased donor or living donors.
-
Professional Background
Education
- 1977 - Clinical Fellowship - Gastroenterology - Vanderbilt University Medical School
- 1974 - Residency - Medicine - Vanderbilt University Medical School
- 1973 - Internship - Medicine - Vanderbilt University Medical School
- 1972 - MD - Medicine - University of Texas Southwestern Medical School at Dallas
- 1968 - PhD - Biology - Rice University
- 1966 - MA - Biology - Rice University
- 1965 - BA - Biology - Rice University
Appointments
- 8/1996 - Associate Medical Director - University Health SystemSan Antonio
- 1/1993 - Medical Director - UT Health Science Center, Medicine, San Antonio
- 6/1988 - Professor and Faculty Physician - UT Health Science Center, Medicine, San Antonio
- 6/1988 - Staff Physician - University Health System, Medicine, San Antonio
-
Instruction & Training
- 7/2005 - Present, Post-Doctoral Student Supervision, UTHSCSA
- 7/2005 - Present, Post-Doctoral Student Supervision, UTHSCSA
-
Research & Grants
Project #: 118375
Funding Agency: IDUN Pharmaceuticals
Title: Safety, tolerability and efficacy study of a caspase inhibitor, IND-6556 in patients undergoing orthotopic liver transplantation
Status: Complete
Period: 12/2003 - 01/2005
Role: Co-Investigator
% Effort:
Total Costs: $170,000.00
Grant Detail: Second lead enrolling site; publication in process
Grants
Private
Funding Agency Roche Title Mycophenolate mofetil in treatment of hepatitis C virus infection Status Complete Period 6/2002 - 1/2029 Role Co-Investigator Grant Detail
-
Publications
Book Chapter
1.Espinoza A, Speeg KV, Washburn K, Halff G. Liver Transplantation In: Espinoza A, Speeg, Washburn K, Halff G. Essential Emergency Medicine for the Healthcare Practitioner. Saunders-Elsevier; 2007.
2. Speeg KV, Halff GA, Schenker S. Metabolism of drugs before and after liver transplantation. In: Maddrey WC, Schiff E, Sorrell MF. Transplantation of the Liver, 3rd Ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
Journal Article
Lee SM, Speeg KV, Pollack MS, Sharkey FA. Progression of morphologic changes after transplantation of a liver with heterozyzous alpha-1 antitrypsin deficiency Human Pathology 2012;43:753-756.
2. Sharkey FE, Lytvak I, Prihoda TJ, Speeg KV, Washburn WK, Halff GA.. High-grade Microsteatosis and Delay in Hepatic Function after Orthotopic Liver Transplantation Human Pathology 2011:1337-1342.
-
Clinical
Board Certifications
- 1976 - American Board of Internal Medicine
- 1973 - National Board of Medical Examiners